Eris Lifesciences informs about cessation of director

18 Dec 2025 Evaluate
Eris Lifesciences has informed that the members of the Company had at their Fifteenth Annual General Meeting held on September 01, 2021, approved the appointment of Rajeev Dalal (DIN: 00222650) as a Non-Executive, Independent Director of the Company, to hold office for a term of five (consecutive) years commencing from December 19, 2020, to December 18, 2025. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (‘SEBI Listing Regulations’), the term of appointment of Rajeev Dalal as a Non-Executive, Independent Director of the Company shall end on December 18, 2025. Consequently, Rajeev Dalal will cease to be a Non-Executive, Independent Director of the Company with effect from the close of business hours on December 18, 2025. Consequent upon the completion of the term of Rajeev Dalal, as a Non-Executive, Independent Director of the Company, his membership and chairmanship in various committees of the Board also cease to exist. The Board of Directors and Management of the Company extend their sincere appreciation for the valuable contributions made by Rajeev Dalal during his term. The relevant details pursuant to Regulation 30 read with Schedule III of the SEBI Listing Regulations, 2015, read with circular no. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, and SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, are enclosed as Annexure.

The above information is a part of company’s filings submitted to BSE.

Eris Lifesciences Share Price

1553.20 -9.65 (-0.62%)
18-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1745.35
Dr. Reddys Lab 1279.60
Cipla 1499.10
Zydus Lifesciences 913.85
Lupin 2118.25
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×